Researchers at the University of Texas (UT) have developed a vaccine that could support the body to attack Alzheimer’s plaques and tangles before they begin to lock up the brain. Alzheimer’s is the most common form of dementia found in older. The beta-amyloid proteins get stuck together and form tangles of tau proteins in the brain inhibiting neural connections. The new vaccine has targeted both amyloid-containing plaques and tau in a mouse with the disease and expected to test in human soon. The shot uses DNA from Alzheimer’s proteins to edify the immune system to clash these compounds from accumulating in the brain. Researchers say their new Alzheimer’s vaccine—so-called DNA Aβ42—could feasibly cut the number of dementia cases in half.
Related Posts
Levofloxacin: A Game-Changer in Preventing Deadly Drug-Resistant Tuberculosis
A cost-effective antibiotic, levofloxacin, has been identified as a potent tool in reducing the risk of contracting drug-resistant tuberculosis (MDR-TB). Tuberculosis, the second deadliest infectious disease globally, poses a significant threat, especially in developing countries where access to treatment is limited. South African research, presented at the Union World Conference on Lung Health, reveals a […]
Unprecedented Storm Hits California: Tropical Storm Hilary Wreaks Havoc
California is facing an unprecedented weather crisis as Tropical Storm Hilary brought heavy rains, prompting a state of emergency declaration by Governor Gavin Newsom. The storm, originally Hurricane Hilary, struck the Baja California peninsula before heading to California, packing winds of 60 mph. Officials warned of catastrophic flooding in Baja California and the southwestern US. […]
PLOS supports the idea to Improve Transparency for Author Contributions
A group of scientific organizations met under the aegis of the US National Academy of Sciences to discuss ways to improve the transparency of author contributions. The recommendations were based on feedback from stakeholders including universities, research institutions, funding agencies and scientific societies. Some of the recommendations have already been implemented by PLOS. Reference link: […]